Last reviewed: June 27, 2026
Last updated: June 27, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, a GLP-1 receptor agonist, works best when doses increase gradually over weeks and months. Most people begin at lower doses and move upward based on their body's response and tolerance. PlexusDx provides compounded semaglutide injections starting at $149 per month, delivered to all 50 states without insurance requirements.
How Semaglutide Dosing Works: The Titration Schedule
Semaglutide dosing follows a structured four-week escalation protocol. Your healthcare provider typically starts you at 0.25 mg weekly, then advances by 0.25 mg increments every four weeks until reaching your therapeutic dose. This measured approach allows your body to adapt while reducing nausea, vomiting, and gastrointestinal discomfort that some people experience early in treatment.
The standard target dose for weight management ranges from 1.0 mg to 2.4 mg weekly, though some patients benefit from intermediate doses like 1.7 mg. Your provider determines the right level based on your metabolic response, existing health conditions, and how well you tolerate each stage. Most people reach their optimal dose within 16 to 20 weeks of starting therapy.
PlexusDx ensures your dose progression never increases your monthly cost. Your monthly commitment remains flat regardless of whether you're on 0.25 mg or 2.4 mg—your dose may need to go up, your price won't. This transparent pricing model removes barriers to achieving your target therapeutic level.
Signs Your Healthcare Provider May Recommend a Dose Increase
Several clinical indicators suggest you're ready for your next dose level. If you've tolerated your current injection well for four weeks with minimal side effects, and your appetite remains elevated or hunger returns, a dose increase may help deepen your weight loss response. Additionally, if your weekly weight loss plateau has lasted two or more weeks despite dietary adherence, stepping up your dose can reignite progress.
Your healthcare provider also considers your blood sugar control and metabolic markers. If your fasting glucose or HbA1c remains higher than your target range, advancing semaglutide dosing strengthens its glucose-lowering effect. Patients with type 2 diabetes often require higher doses to achieve both weight loss and optimal glycemic control simultaneously.
One important caveat: dose increases depend on your tolerance profile. If you're experiencing persistent nausea, vomiting, or constipation at your current level, your provider may recommend staying put longer, adjusting lifestyle factors, or adding symptom-management strategies before advancing. Never increase your dose on your own—work directly with your PlexusDx-affiliated healthcare provider.
Timeline Expectations: From Initial Dose to Maintenance Level
Most patients reach their maintenance dose within four to five months of starting semaglutide therapy. The typical timeline begins with 0.25 mg in week one, progresses to 0.5 mg by week five, 1.0 mg by week nine, and 1.7 to 2.4 mg by week 13 or beyond. This gradual approach mirrors how clinical trials established both efficacy and tolerability.
During months two through four, you'll likely notice your strongest weight loss phase. Research published in major endocrinology journals shows that participants on semaglutide lose 10% to 15% of their baseline body weight by month four, with continued losses through month six. Once you stabilize at your target dose, weight loss velocity may slow slightly but remains consistent over the following months.
After reaching your maintenance dose, most people continue indefinitely to sustain their weight loss. Stopping semaglutide before your health goals are met typically leads to weight regain within weeks. PlexusDx supports long-term therapy with straightforward monthly pricing and ongoing provider guidance to keep you progressing toward your targets.
Genetic Insights Into Your Semaglutide Response With PlexusDx
How your body responds to semaglutide depends partly on your genetic makeup at key metabolic control points. The Precision Peptide Genetic Test offered by PlexusDx analyzes variants in GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)—genes that directly influence your appetite regulation and weight loss capacity. Understanding your peptide-pathway genetics helps your healthcare provider predict which dose level will work best for you.
Certain genetic profiles show stronger GLP-1 receptor sensitivity, meaning lower doses trigger robust appetite suppression and metabolic shifts. Others carry variants associated with higher setpoint weight or reduced satiety signaling, often benefiting from faster progression to higher doses or combination therapies like GLP-Squared (semaglutide plus tirzepatide). PlexusDx maps 14 peptide pathways across 150+ genetic insights to personalize your treatment plan.
Adding the Precision Peptide Genetic Test for $99 after your first month of semaglutide therapy provides a roadmap for your healthcare provider. Rather than guessing whether you should advance doses or switch medications, genetic data informs a precision approach tailored to your biology. This insight improves both outcomes and your confidence in your treatment direction.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the typical semaglutide starting dose?
Most patients begin at 0.25 mg once weekly, injected subcutaneously. After four weeks of good tolerance, your healthcare provider advances to 0.5 mg, then continues increasing by 0.25 mg increments monthly until reaching your therapeutic target, usually 1.7 to 2.4 mg weekly. PlexusDx compounded semaglutide starts at $149 per month flat, regardless of your dose level.
How long does it take to see weight loss results on semaglutide?
Most people notice appetite suppression within days of their first injection, but measurable weight loss typically appears by week three to four. Clinical trial data shows average losses of 5 pounds by month two, accelerating to 10–15 pounds by month four as you reach higher therapeutic doses. Individual results vary based on diet, exercise, and genetic response factors.
Can I increase my semaglutide dose faster than the standard schedule?
No. Accelerating beyond the standard four-week intervals between dose increases significantly raises your risk of severe nausea, vomiting, and gastrointestinal side effects without improving outcomes. Your healthcare provider follows evidence-based titration protocols to balance efficacy with tolerability. Always work with your provider before making any dose changes.
What happens if I can't tolerate a higher semaglutide dose?
If side effects become unmanageable at a new dose level, your provider may pause progression, reduce to your previous dose temporarily, or add supportive medications like anti-nausea agents. Some patients achieve excellent results at intermediate doses like 1.0 or 1.7 mg rather than the maximum 2.4 mg. Your treatment should be sustainable long-term.
How does the Precision Peptide Genetic Test help with semaglutide dosing?
PlexusDx's Precision Peptide Genetic Test identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R—pathways directly controlling appetite and metabolic rate. Patients with high-sensitivity GLP1R variants often respond powerfully to lower doses, while those with certain FTO variants may need higher doses or dual-compound therapy. This $99 test guides your provider toward your optimal dose faster.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Lightheadedness a Side Effect of Ozempic?
Can a Non-Diabetic Take Mounjaro for Weight Loss? Exploring Your Options with Personalized Care